Table 3.
Clinico-Pathological Value Of MIR22HG Expression In HCC From mRNA-Seq Data
| Clinico-Pathological Feature | N | MIR22HG Relevant Expression | |||
|---|---|---|---|---|---|
| M ± SD | t | P | |||
| Tissue | Cancer | 374 | 2.879 ± 0.948 | −8.63 | <0.001 |
| Normal | 225 | 3.678 ± 1.179 | |||
| Gender | MALE | 250 | 2.860 ± 0.954 | −0.872 | 0.384 |
| FEMALE | 121 | 2.951 ± 0.927 | |||
| Age | >60 | 193 | 2.957 ± 0.904 | 1.514 | 0.131 |
| ≤60 | 177 | 2.808 ± 0.981 | |||
| Stage | III-IV | 90 | 2.733 ± 1.035 | 1.486 | 0.138 |
| I-II | 257 | 2.904 ± 0.905 | |||
| M stage | M1 | 4 | 2.009 ± 0.619 | 1.648 | 0.101 |
| M0 | 266 | 2.814 ± 0.973 | |||
| N stage | N1 | 4 | 3.330 ± 1.497 | −1.071 | 0.285 |
| N0 | 252 | 2.808 ± 0.960 | |||
| T stage | T3-4 | 93 | 2.746 ± 0.993 | 1.647 | 0.100 |
| T0-2 | 275 | 2.932 ± 0.926 | |||
| Grade | G3-4 | 134 | 2.734 ± 0.991 | 2.365 | 0.019 |
| G1-2 | 232 | 2.976 ± 0.912 | |||
Notes: Unpaired sample t test was performed to evaluate the clinico-pathological parameters of HCC. P<0.05 was considered statistically significant.
Abbreviations: N, number; M, mean; SD, standard deviation.